Page 123 - 2019_07 resto del Mondo-web

Genomic landscape of B-other ALL
Figure 3. Graphical overview of clinical characteristics, the analyses performed and the genetic findings in 110 B-other acute lymphoblastic leukemia (ALL) patients grouped by ALL subtype. Patients are ordered according to the ALL subtype; demographic and clinical data are shown above, while genetic data are dis- played below the ALL subtype track. Recurrently affected genes are arranged according to functional categories. Epigen.: epigenetic regulators/modifiers; MPAL: BCP-myeloid mixed phenotype acute leukemia; Dg WBC; initial white blood cell count (cells/μL); y: years; FC: flow cytometry; SR: standard risk; MR: medium risk; HR: high risk; Neg: negative; Pos: positive; ncounts: normalized counts. For definitions of good and poor prednisone response, polymerase chain reaction (PCR) minimal residual disease (MRD) risk, and final risk group stratification see Table 1, Online Supplementary Methods and Online Supplementary Table S6.
haematologica | 2019; 104(7)
1401